273 related articles for article (PubMed ID: 29588131)
21. Effect of Micronized Purified Flavonoid Fraction Therapy on Endothelin-1 and TNF-α Levels in Relation to Antioxidant Enzyme Balance in the Peripheral Blood of Women with Varicose Veins.
Pietrzycka A; Kózka M; Urbanek T; Stpniewski M; Kucharzewski M
Curr Vasc Pharmacol; 2015; 13(6):801-8. PubMed ID: 26311575
[TBL] [Abstract][Full Text] [Related]
22. Clinical efficacy of micronized purified flavonoid fraction (MPFF) in edema.
Olszewski W
Angiology; 2000 Jan; 51(1):25-9. PubMed ID: 10667640
[TBL] [Abstract][Full Text] [Related]
23. Effects of Citrus Flavonoids Against Microvascular Damage Induced by Hypoperfusion and Reperfusion in Rat Pial Circulation.
Mastantuono T; Battiloro L; Sabatino L; Chiurazzi M; Di Maro M; Muscariello E; Colantuoni A; Lapi D
Microcirculation; 2015 Jul; 22(5):378-90. PubMed ID: 25944567
[TBL] [Abstract][Full Text] [Related]
24. Effects of the phlebotropic drug Daflon 500 mg on postischemic microvascular disturbances in striated skin muscle: an intravital microscopic study in the hamster.
Nolte D; Pickelmann S; Möllmann M; Schütze E; Kübler W; Leiderer R; Messmer K
J Lab Clin Med; 1999 Nov; 134(5):526-35. PubMed ID: 10560947
[TBL] [Abstract][Full Text] [Related]
25. Effect of a micronized purified flavonoid fraction on in vivo platelet functions in the rat.
McGregor L; Bellangeon M; Chignier E; Lerond L; Rousselle C; McGregor JL
Thromb Res; 1999 May; 94(4):235-40. PubMed ID: 10336239
[TBL] [Abstract][Full Text] [Related]
26. Micronized purified flavonoid fraction (MPFF): a review of its pharmacological effects, therapeutic efficacy and benefits in the management of chronic venous insufficiency.
Katsenis K
Curr Vasc Pharmacol; 2005 Jan; 3(1):1-9. PubMed ID: 15641940
[TBL] [Abstract][Full Text] [Related]
27. [Ultrasound elastography in assessing efficacy of treatment for lower limb varicose veins with a phlebotrophic drug containing a micronized purified flavonoid fraction].
Zubarev AR; Krivosheeva NV; Demidova aK; Rychkova IV
Angiol Sosud Khir; 2014; 20(2):90-6. PubMed ID: 24961330
[TBL] [Abstract][Full Text] [Related]
28. Micronized purified flavonoid fraction for the treatment of chronic venous insufficiency, with a focus on postthrombotic syndrome: A narrative review.
Li KX; Diendéré G; Galanaud JP; Mahjoub N; Kahn SR
Res Pract Thromb Haemost; 2021 May; 5(4):e12527. PubMed ID: 34027293
[TBL] [Abstract][Full Text] [Related]
29. From symptoms to leg edema: efficacy of Daflon 500 mg.
Nicolaides AN
Angiology; 2003; 54 Suppl 1():S33-44. PubMed ID: 12934755
[TBL] [Abstract][Full Text] [Related]
30. Chronic venous insufficiency: worldwide results of the RELIEF study. Reflux assEssment and quaLity of lIfe improvEment with micronized Flavonoids.
Jantet G
Angiology; 2002; 53(3):245-56. PubMed ID: 12025911
[TBL] [Abstract][Full Text] [Related]
31. VEIN STEP: A Prospective, Observational, International Study to Assess Effectiveness of Conservative Treatments in Chronic Venous Disease.
Mezalek ZT; Feodor T; Chernukha L; Chen Z; Rueda A; Sánchez IE; Ochoa AJG; Chirol J; Blanc-Guillemaud V; Lohier-Durel C; Ulloa JH
Adv Ther; 2023 Nov; 40(11):5016-5036. PubMed ID: 37728696
[TBL] [Abstract][Full Text] [Related]
32. HR, 0-(beta-hydroxyethyl)-rutosides, in comparison with diosmin+hesperidin in chronic venous insufficiency and venous microangiopathy: an independent, prospective, comparative registry study.
Cesarone MR; Belcaro G; Pellegrini L; Ledda A; Di Renzo A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cacchio M
Angiology; 2005; 56(1):1-8. PubMed ID: 15678250
[TBL] [Abstract][Full Text] [Related]
33. Effects of oral administration of different doses of purified micronized flavonoid fraction on microvascular reactivity after ischaemia/reperfusion in the hamster cheek pouch.
Bouskela E; Cyrino FZ; Lerond L
Br J Pharmacol; 1997 Dec; 122(8):1611-6. PubMed ID: 9422805
[TBL] [Abstract][Full Text] [Related]
34. Use of Micronized Purified Flavonoid Fraction Together with Rivaroxaban Improves Clinical and Ultrasound Outcomes in Femoropopliteal Venous Thrombosis: Results of a Pilot Clinical Trial.
Lobastov K; Schastlivtsev I; Barinov V
Adv Ther; 2019 Jan; 36(1):72-85. PubMed ID: 30539384
[TBL] [Abstract][Full Text] [Related]
35. Flavonoids. A review of the pharmacology and therapeutic efficacy of Daflon 500 mg in patients with chronic venous insufficiency and related disorders.
Struckmann JR; Nicolaides AN
Angiology; 1994 Jun; 45(6):419-28. PubMed ID: 8203767
[TBL] [Abstract][Full Text] [Related]
36. Neuroprotective and hepatoprotective effects of micronized purified flavonoid fraction (Daflon®) in lipopolysaccharide-treated rats.
Abdel-Salam OM; Youness ER; Mohammed NA; Abd-Elmoniem M; Omara E; Sleem AA
Drug Discov Ther; 2012 Dec; 6(6):306-14. PubMed ID: 23337818
[TBL] [Abstract][Full Text] [Related]
37. Micronized Purified Flavonoid Fraction (MPFF) for Patients Suffering from Chronic Venous Disease: A Review of New Evidence.
Ulloa JH
Adv Ther; 2019 Mar; 36(Suppl 1):20-25. PubMed ID: 30758743
[TBL] [Abstract][Full Text] [Related]
38. The Benefits of Micronized Purified Flavonoid Fraction (MPFF) Throughout the Progression of Chronic Venous Disease.
Nicolaides AN
Adv Ther; 2020 Feb; 37(Suppl 1):1-5. PubMed ID: 31970659
[TBL] [Abstract][Full Text] [Related]
39. A flavonoid fraction purified from Rutaceae aurantiae (Daflon(R)) inhibiting AGE formation, reduces urinary albumin clearance and corrects hypoalbuminemia in normotensive and hypertensive diabetic rats.
Urios P; Kassab I; Grigorova-Borsos AM; Guillot R; Jacolot P; Tessier F; Peyroux J; Sternberg M
Diabetes Res Clin Pract; 2014 Sep; 105(3):373-81. PubMed ID: 24956965
[TBL] [Abstract][Full Text] [Related]
40. Conservative Treatment of Hemorrhoids: Results of an Observational Multicenter Study.
Zagriadskiĭ EA; Bogomazov AM; Golovko EB
Adv Ther; 2018 Nov; 35(11):1979-1992. PubMed ID: 30276625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
